M.D. Anderson's C. Stratton Hill Receives Award From American Cancer Society

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 23 No 5
Volume 23
Issue 5

CHICAGO--The American Cancer Society has presented its Humanitarian Award to C. Stratton Hill, Jr., MD, of the University of Texas M.D. Anderson Cancer Center. The award is given for dedication to thea improvement of cancer control and genuine accomplishment in human welfare.

CHICAGO--The American Cancer Society has presented its HumanitarianAward to C. Stratton Hill, Jr., MD, of the University of TexasM.D. Anderson Cancer Center. The award is given for dedicationto thea improvement of cancer control and genuine accomplishmentin human welfare.

As an oncologic endocrinologist, and later as associate directorof clinics at M.D. Anderson, Dr. Hill helped lay the foundationfor what has become the largest oncologic clinic in the world.As director of the Pain Service at M.D. Anderson, Dr. Hill hasworked to improve the state of pain control and has earned aninternational reputation as a leader in this field, working withstate legislatures and pharmacy and narcotic boards.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content